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ABSTRACT: Because of the emergence of antimicrobial
resistance to traditional small-molecule drugs, cationic
antimicrobial polymers are appealing targets. Mycobacterium
tuberculosis is a particular problem, with multi- and total drug
resistance spreading and more than a billion latent infections
globally. This study reports nanoparticles bearing variable
densities of poly(dimethylaminoethyl methacrylate) and the
unexpected and distinct mechanisms of action this multivalent
presentation imparts against Escherichia coli versus Mycobacte-
rium smegmatis (model of M. tuberculosis), leading to killing or
growth inhibition, respectively. A convergent “grafting to” synthetic strategy was used to assemble a 50-member nanoparticle
library, and using a high-throughput screen identiﬁed that only the smallest (2 nm) particles were stable in both saline and
complex cell media. Compared with the linear polymers, the nanoparticles displayed two- and eight-fold enhancements in
antimicrobial activity against M. smegmatis and E. coli, respectively. Mechanistic studies demonstrated that the antimicrobial
particles were bactericidal against E. coli due to rapid disruption of the cell membranes. Conversely, against M. smegmatis the
particles did not lyse the cell membrane but rather had a bacteriostatic eﬀect. These results demonstrate that to develop new
polymeric antituberculars the widely assumed, broad spectrum, membrane-disrupting mechanism of polycations must be
re-evaluated. It is clear that synthetic nanomaterials can engage in more complex interactions with mycobacteria, which we
hypothesize is due to the unique cell envelope at the surface of these bacteria.
■ INTRODUCTION
Infectious diseases are the second-leading cause of death
worldwide and the third-leading cause of death in economically
advanced countries.1 Microbial infection remains one of the
most serious complications in medical equipment and instru-
mentation, food packaging, and food storage. Reisner and
Woods found that 85−90% of all clinically reported infections
are caused by only seven microorganisms with Escherichia coli
and Staphylococcus aureus accountable for approximately half of
all infections.2 Tuberculosis (TB) remains one of the top ten
causes of death worldwide, causing an estimated 1.8 million
deaths annually.3 Most worrying is the rise of drug resistance:
In 2015 there was an estimated 480 000 new cases of multi-
drug-resistant TB. Despite a steady stream of potential targets
being discovered through developments in genomics and
proteomics, antibiotic development in the industry has declined
alarmingly.1,4,5 Because of the intense use and misuse of
antibiotics, antibiotic resistance is now one of the most pressing
global healthcare problems facing today’s society,4,6,7 and a lack
of available treatments is becoming a very real possibility for
some infections.8 There is, therefore, a pressing need for new
and nontraditional solutions, which includes diagnostics,
improved prescribing,9,10 control measures, and new drugs
alongside a better understanding of the host−pathogen
interactions.3
Antimicrobial peptides (AMPs) have had considerable
attention as potential new lead antibiotics.11−13 It is
hypothesized that their mode of action is to bind to negatively
charged phospholipid head-groups present on the bacterial
membrane, followed by the induction of membrane permeabi-
lization, pore formation, and ultimately cell death,12,14
rather than targeting a speciﬁc enzyme, as small-molecule
drugs typically do. While AMPs show potential as antimicrobial
agents, the expense of large-scale peptide synthesis, protease
susceptibility, biocompatibility issues, and toxicity need to be
overcome. Cationic polymers have been explored as mimics of
AMPs, particularly due to their resistance to proteases and
the vast chemical and architectural space for synthetic poly-
mers.15−23 Tew and coworkers have taken the design rules from
natural AMPs and have shown that facially amphiphilic cationic
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materials can be tuned to be highly active toward Gram-
negative or Gram-positive bacteria.24 They have also demon-
strated that if the facial amphiphilicity is disrupted it switches
oﬀ the activity toward a Gram-negative bacterial strain but is
maintained against a Gram-positive strain.21
It has been shown that placing cationic polymers on
multivalent scaﬀolds can dramatically enhance their aﬃnity
with the bacterial cytoplasmic membrane.25−29 By displaying
multiple copies of the cationic polymer, a high density of
positive charge is created, leading to an increase in adsorption
onto negatively charged bacterial membranes. Qiao and
coworkers have reported that 16- and 32-arm star branched
polycations containing valine (isopropyl) and lysine (primary
amine) functionalities were active under in vivo mimicking
environments such as simulated body ﬂuid against a range of
Gram-negative, ESKAPE pathogens, E. coli, Klebsiella pneumo-
niae, and P. aeruginosa.30 The group went on to show that these
polycations are eﬀective against Acinetobacter baumannii in vivo.
They also found that the bacteria did not grow resistant to the
polycations over 600 generations. The star-branched polymers
were found to disrupt the outer membrane of the bacteria and
trigger cell-death pathways.31
Gold nanoparticles (AuNPs) have been used as an alternative
to generate dense polycations. AuNPs are a versatile platform
based on their useful optical and physical properties. Bunz
et al.28 reported that cationic 2 and 6 nm AuNPs interact with
cell membrane of Gram-positive (Bacillus subtilis) and Gram-
negative (E. coli) bacteria, resulting in aggregation on the cell
surface. Interestingly, 6 nm AuNPs were found not to lyse
either of the strains, whereas 2 nm AuNPs rapidly lysed
B. subtilis but not E. coli. Following on from this, Rotello et al.26
changed the quarternizing group on these 2 nm particles and
found that activity increased as hydrophobicity of the
quarternizing group increases. Feldheim et al.32 showed that
∼2 nm particles with speciﬁc mixtures of 4-mercaptobenzoic
acid, cysteamine, 3-mercapto-1-propanesulfonic acid, and
2-diethylaminoethanethiol on their surface showed increased
activity againstM. smegmatis over E. coli. None of these particles
lead to signiﬁcant membrane disruption, though, implying that
nonlytic mechanisms are an untapped route to modulate
bacteria growth and infection with cationic polymers. Gibson
and coworkers33 have observed that poly(2-dimethylamino)-
ethyl methacrylate (PDMAEMA) can selectively target
M. smegmatis over Gram-negative strains such as E. coli and
Pseudomonas putida and that PDMAEMA also did not lyse the
mycobacterial cell membrane. Gram-negative bacteria have an
inner and outer membrane, and hence these are typically harder
to lyse than Gram-positive bacteria, which lack the outer mem-
brane. However, mycobacteria are a unique subclass, which
have a specialized thick layer of complex polysaccharides and
lipids on their surface.34 This provides a physical barrier, enabling
the pathogen to survive intracellularly in macrophages but also a
physical barrier to drugs, which could include polycations.
Therefore, disrupting this is likely to require design rules very
diﬀerent from, for example, E. coli.
Considering the above, this manuscript reports a detailed
study into the use of “multicopy” multivalent nanoparticles and
their antimicrobial activity against mycobacteria and also a
Gram-negative strain. The particles are engineered to generate
diversity in terms of size and cationic polymer density to ensure
colloidal stability (preventing false-positives). The signiﬁcant
enhancements in antimicrobial activity upon changing from
single polymer chains to polymer-immobilized nanoparticles
are reported, along with discovery of very diﬀerent modes of
action between the diﬀerent strains.
■ EXPERIMENTAL SECTION
Materials. 2-(Dimethylamino)ethyl methacrylate (98%)
4,4′-azobis(4-cyanovaleric acid) (>98%) mesitylene (analytical stand-
ard) N-hydroxyethyl acrylamide (97%), dioxane, methanol, toluene,
tetrahydrofuran, pentane, gold(III) chloride trihydrate (>99.9%),
sodium citrate tribasic dihydrate (>99%), sodium borohydride, and
propidium iodide (>94%) were purchased from Sigma-Aldrich and
used as supplied unless otherwise stated. SYTO-9 green ﬂuorescent
nucleic acid stain was purchased from ThermoFischer Scientiﬁc.
2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid was synthe-
sized as previously described.43 Ovine red blood cells were supplied by
TCS Biosciences.
Physical and Analytical Methods. SEC analysis was performed
using a Varian 390-LC MDS system equipped with a PL-AS RT/MT
autosampler, a PL-gel 3 μm (50 Å∼ 7.5 mm) guard column, and two
PL-gel 5 μm (300 Å∼ 7.5 mm) mixed-D columns using DMF with
5 mM NH4BF4 at 50 °C as eluent at a ﬂow rate of 1.0 mL·min
−1.
The SEC system was equipped with ultraviolet (UV)/visible (set at
280 and 461 nm) and diﬀerential refractive index (DRI) detectors.
Narrow-molecular-weight PMMA standard (200−1.0 Å∼ 106 g mol−1)
was used for calibration using a second-order polynomial ﬁt. NMR
spectroscopy (1H, 13C) was conducted on a Bruker DPX-300 using
deuterated chloroform or methanol as a solvent. Fluorescence
microscopy was performed on a Nikon Eclipse Ti, inverted wide-
ﬁeld ﬂuorescence microscope equipped with LED illumination, a 100×
1.45 NA objective, mCherry and GFP ﬁlter sets, and a 2k × 2k
sCMOS Andor camera system. Transmission electron microscopy
(TEM) was performed on a JEOL 2100 instrument at 200 kV, and
images obtained were analyzed using ImageJ software.
Synthetic Section. Polymerization of Dimethylaminoethyl
Methacrylate. In a typical reaction, 2-(dimethylamino)ethyl methya-
crylate (0.5 g, 3.2 mmol), 2-(dodecylthiocarbonothioylthio)-2-
methylpropionic acid (23.2 mg, 0.64 mmol), and 4,4′-azobis(4-
cyanovaleric acid) (3.6 mg, 0.13 mmol) were dissolved in dioxane
(4 mL) in a glass vial. Mesitylene (100 μL) was added as an internal
reference. A 25 μL aliquot was taken for 1H NMR analysis in CDCl3.
The vial was ﬁtted with a rubber septum and the solution was degassed
by bubbling with nitrogen gas for 30 min. The vial was then placed in a
thermostated water bath at 70 °C for 16 h. After this time, the reaction
was opened to air and quenched in liquid nitrogen. A 25 μL aliquot
was taken for 1H NMR analysis in CDCl3, and conversion was
determined against mesitylene standard. The product was puriﬁed by
precipitation from tetrahydrofuran into pentane and dried under
vacuum. See Table 1 for analysis.
Polymerization of N-Hydroxyethyl Acrylamide. In a typical
reaction, N-hydroxyethyl acrylamide (0.5 g, 4.3 mmol), 2-(dodecylth-
iocarbonothioylthio)-2-methylpropionic acid (31.7 mg, 0.87 mmol),
and 4,4′-azobis(4-cyanovaleric acid) (4.9 mg, 0.17 mmol) were
dissolved in 1:1 methanol/toluene (4 mL) in a glass vial. Mesitylene
(100 μL) was added as an internal reference. A 25 μL aliquot was
taken for 1H NMR analysis in CDCl3. The vial was ﬁtted with a rubber
septum, and the solution was degassed by bubbling with nitrogen gas
for 30 min. The vial was then placed in a thermostated water bath at
70 °C for 90 min. After this time, the reaction was opened to air and
quenched in liquid nitrogen. A 25 μL aliquot was taken for 1H NMR
analysis in MeOD, and conversion was determined against mesitylene
standard. The product was puriﬁed by precipitation from methanol
into diethyl ether and dried under vacuum. See Table 1 for analysis.
Synthesis of Citrate-Stabilized Gold Nanoparticles. HAuCl4
(114.4 mg, 0.29 mmol) in 350 mL of milli-Q H2O was heated to
reﬂux under vigorous stirring. To this, sodium citrate tribasic dihydrate
(299 mg, 1.02 mmol for ∼15 nm and 214 mg, 0.73 mmol for ∼30 nm)
in 10 mL of milli-Q H2O was added in a single portion. The reaction
was maintained at reﬂux for 30 min, during which a deep-red coloration
formed. The reaction was allowed to cool to room temperature.
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Assuming complete reduction of the HAuCl4, the total gold concen-
tration was 0.83 mM (0.16 mg·mL−1).
For ∼5 nm citrate-stabilized gold nanoparticles, to HAuCl4
(19.8 mg, 0.05 mmol) in 240 mL of milli-Q H2, sodium citrate
tribasic dihydrate (13.8 mg, 0.05 mmol) was added. To this, NaBH4
(18.5 mg, 0.5 mmol) in ice-cold milli-Q H2O was added and stirred at
room temperature overnight. Assuming complete reduction of the
HAuCl4 the total gold concentration was 0.21 mM (0.04 mg·mL
−1).
Particles were concentrated using an Amicon Ultra-15 10 kDa MWC
centrifugal dialysis unit.
Functionalization of Preformed Gold Nanoparticles with RAFT-
Derived Polymers. 100 μL of a 10 mg·mL−1 polymer solution in milli-
Q water was added to a 1 mL solution of gold nanoparticles
(0.83 mM) and left on a rolling stirrer for 30 min. Unattached polymer
was removed by three centrifugation−resuspension cycles (10 000g,
15 min). Amicon-4 30 kDa centrifugal dialysis ﬁlters were required to
remove unattached polymer from ∼5 nm particles.
Synthesis of 2 nm Particles. ∼2 nm particles were synthesized
using a modiﬁed procedure from Cameron et al.40 0.5 mM HAuCl4 in
25 mL of milli-Q H2O and 5.0 mM polymer (DP100 PDMAEMA,
PHEA, or a mix of the two) in 0.5 mL of milli-Q H2O were combined
under vigorous stirring. 50 mM sodium borohydride in 5 mL of milli-
Q H2O was added in a single portion. An immediate color change
from yellow to brown was observed. Stirring was continued for 3 h.
Particles were concentrated, and unattached polymer was removed
using an Amicon Ultra-15 10 kDa MWC centrifugal dialysis unit.
Microbiology Section. Bacterial Strains and Growth Con-
ditions. Mycobacterium smegmatis MC2155 was grown in Middlebrook
7H9 media supplemented with 0.2% glycerol and 0.05% Tween 80.
Escherichia coli Top10 were grown in Luria−Bertani (LB) media.
For MBCs and CFUs bacteria were grown on LB agar containing no
antibiotics.
Determination of Antibacterial Activities of 2 nm Particles.
Minimum inhibitory concentration (MIC99) of the particles was deter-
mined against M. smegmatis and E. coli. The bacteria were cultured to
mid-log phase and the inoculum was standardized to 1 × 105
CFU.mL−1 before addition to a 96-well microtiter plate in which the
particles were serially diluted two-fold across the plate. Control wells
contained culture controls and reference antibiotics (rifampicin for
M. smegmatis and ampicillin for E. coli). The plates were incubated in a
static incubator for 16 h for E. coli and 24 h for M. smegmatis.
Following this incubation period, 25 μL of resazurin (one tablet
(VWR) in 30 mL of sterile PBS) was added and left for a further
incubation for 24 h for M. smegmatis and 2 h for E. coli. The MIC99
values were determined as the lowest concentration of particles at
which the color did not change of resazurin (blue, no bacterial growth)
to resoruﬁn (pink, bacterial growth). The MIC99 values were deter-
mined in triplicate.
Minimal Bactericidal Concentration Determination. Minimum
bactericidal concentration (MBC) of the particles were determined
against M. smegmatis and E. coli. The bacteria were cultured to mid-log
phase and the inoculum was standardized to 1 × 105 CFU.mL−1 before
the addition to a 96-well microtiter plate in which the particles were
serially diluted two-fold across the plate. The plates were incubated in
a static incubator for 16 h for E. coli and 24 h for M. smegmatis.
Following this incubation period, 100 μL of each culture was plated
onto LB agar and incubated at 37 °C for 24 h for E. coli and 48 h
for M. smegmatis. The MBC values were determined as the lowest
concentration of particles that resulted in the observation of no
bacterial growth. The MBC values were determined in triplicate.
Fluorescence Microscopy. LIVE/DEAD viability testing was carried
out using a protocol from Molecular Probes. M. smegmatis and E. coli
were grown to late-log phase (OD 0.8) before being harvested by
centrifugation at 3300g for 15 min at room temperature. The cell
pellet was resuspended in 0.85% NaCl, then aliquoted and incubated
with 0.5 × MIC99 (3.90625 mg·mL
−1 for E. coli and 1.953125 mg·mL−1
or M. smegmatis) and 2 × MIC99 (15.625 mg·mL
−1 for E. coli
and 7.8125 mg·mL−1 or M. smegmatis) of 100% PDMAEMA AuNPs
for 15 min at room temperature. An aliquot was used as a live-cell
control incubated with no particles, and a further aliquot was used as a
heat-killed cells control, incubated at 80 °C for 30 min. After incu-
bation, all samples were washed with 0.85% NaCl twice and
resuspended in 0.85% NaCl. LIVE/DEAD bacterial viability dyes
were used to determine membrane viability. In brief, SYTO-9
(3.34 mM in DMSO) and propidium iodide (20 mM in DMSO)
were used in a 1:1 ratio, and 3 μL of the dye mixture was added for
1 mL of the bacterial suspension in 0.85% NaCl before incubating for
15 min in the dark. Five μL of the stained bacterial suspension was
imaged using a Nikon Eclipse Ti inverted wideﬁeld ﬂuorescence
microscope equipped with LED illumination (at 100 × magniﬁcation)
using GFP (excitation 470/40 nm, emission 525/50 nm) and mCherry
(excitation 560/40 nm, emission 630/75 nm) ﬁlter sets to visualize the
SYTO-9 and propidium iodide staining, respectively.
Hemolysis and Hemagglutination. Ovine red blood cells were
pelleted by centrifugation at 6000g for 5 min, and the supernatant was
removed and resuspended in PBS buﬀer. Particles were serially diluted
two-fold in PBS, and 250 μL of particles was incubated with 250 μL of
ovine red blood cells and incubated at room temperature for 1 h.
For hemagglutination determination 25 μL of this mixture was added to
75 μL of PBS in a U-bottom 96-well plate and incubated for a further
hour at room temperature. Polyethylenimine was used as a positive
control for hemagglutination and cells in PBS alone as a negative
control. Hemagglutination was determined visually by creation of a
pellet (hemagglutination negative) or a blood ﬁlm (hemagglutination
positive). For hemolysis testing the rest of the particle−blood mixture
was centrifuged at 6000g, and 10 μL of the supernatant was added to
90 μL of PBS buﬀer in a 96-well plate. The absorbance was measured at
450 nm and compared against deionized water as a positive control for
lysis and PBS as a negative control to determine % hemolysis.
■ RESULTS AND DISCUSSION
Antimicrobial polymers were prepared by reversible addition−
fragmentation chain transfer (RAFT) polymerization of
2-dimethylaminoethyl methacrylate (DMAEMA).33 An uncharged,
noninteracting polymer, poly(N-hydroxyethyl acrylamide)
(PHEA), was also chosen to control charge density (vide infra)
Table 1. Characterization of Polymers Synthesized by RAFT Polymerization Used in This Study
polymer [M]:[CTA]a conversion (%)b Mn(th) (g mol
−1)c Mn(SEC) (g mol
−1)d Mw/Mn
d
PHEA10 10 78 1600 2800 1.17
PHEA25 25 81 3300 4900 1.21
PHEA50 50 80 6200 7800 1.22
PHEA100 100 88 11900 13600 1.17
PDMAEMA10 10 79 2000 6300 1.48
PDMAEMA25 25 84 4300 10100 1.63
PDMAEMA50 50 86 8300 16300 1.82
PDMAEMA100 100 89 16100 22500 1.71
aFeed ratio of monomer to chain transfer agent. bDetermined by 1H NMR spectroscopy. cTheoretical number-average molecular weight, calculated
from the feed ratio and percent conversion. dDetermined by size-exclusion chromatography in dimethylformamide (DMF) using poly(methyl
methacrylate) standards. Mw, weight-average molecular weight; Mn, number-average molecular weight.
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because it is an excellent stabilizing ligand for gold nano-
particles in biological media (Figure 1). Four diﬀerent degrees
of polymerization (DP) were targeted for each monomer,
DP10, DP25, DP50, and DP100, to provide a range of
molecular weights to screen for stability and activity. A crucial
design criterion was to employ RAFT polymerization, which
installs a trithiocarbonate end-group at the ω-terminus to
enable direct immobilization on preformed gold nanoparticles
(AuNPs) (vide infra) due to the high aﬃnity of sulfur
for gold surfaces. The produced polymers were characterized
by 1H NMR and size exclusion chromatography (SEC)
(Figure 1C,D). PHEA gave narrow molecular weight distri-
butions, and the predicted molecular weights agreed with the
feed ratio. PDMAEMAs had broader molecular weight distri-
butions, as had been previously observed,33 but are suitable for
the purposes of this investigation.
A panel of citrate-stabilized AuNPs was synthesized using
the established citrate/HAuCl4 reduction approach, with the
additional reductant NaBH4 used to obtain the smallest
nanoparticles.3,4 Table 2 summarizes the produced AuNPs
that were characterized by UV−visible spectroscopy and
dynamic light scattering (DLS), giving diameters of 5−32 nm.
These AuNPs were coated with polymers from Table 1 by a
simple mixing strategy, followed by centrifugation/resuspension
cycles to remove excess polymer.36 The DP10 PDMAEMA-
coated nanoparticles were found to be unstable (rapid aggre-
gation) in PBS; therefore, DP25, DP50, and DP100 polymers
were coated onto the particles as statistical mixtures of PHEA
and PDMEAMA (Figure 2A). Using three sizes of AuNPs, three
polymer chain lengths, and ﬁve diﬀerent ratios of each polymer
(0−100% PHEA/100−0% PDMAEMA), a library of 45 distinct
nanoparticles was obtained. These particles were characterized by
UV−vis spectroscopy and DLS (SI). In each case there was a
slight shift of the surface plasmon resonance (SPR) band to
longer wavelengths (Figure 2C), consistent with polymer grafting,
along with an increase in hydrodynamic diameter of the particles
upon polymer coating (Figure 2B).
Initial screening of the antimicrobial activity of this nano-
particle library (data not shown) lead to inconsistent,
irreproducible results, but these did suggest increased activity
(lower MIC99 value) for the polymer-grafted nanoparticles com-
pared with the polymers alone. In drug delivery, aggregation of
nanoparticles in complex media is a common problem, with
particles often being stable in simple solutions (water/PBS) but
not in, for example, blood,37 which leads to irreproducible
results and low stability upon storage: Therefore, this was
studied in detail before progressing to antimicrobial testing.
Gold nanoparticles are excellent scaﬀolds for studying aggre-
gation as their optical properties change (red−blue color
shift, decrease in SPRmax absorption) upon aggregation, enabl-
ing high-throughput screening by colorimetric assays.37−39
The nanoparticle library prepared here was evaluated for
stability to aggregation in LB broth and Middlebrook 7H9
broth supplemented with 0.2% glycerol and 0.05% Tween 80,
the media used for antimicrobial activity assays. In short, the
nanoparticles were incubated for 16 h in the indicated media in
a 96-well plate. After this time, the UV−vis spectra were
recorded and stability evaluated by assessing the change in
absorbance at 700 nm. Particles were classiﬁed as being
colloidally unstable if this change reached a certain threshold
Figure 1. Synthesis of polymers. (A) PDMAEMA and (B) PHEA. SEC
analysis of (C) PDMAEMA and (D) PHEA, as reported in Table 1.
Table 2. Citrate-Stabilized Gold Nanoparticles Used in This Study
diameter (nm)
particlea citrate:Au NaBH4:Au
b λSPR (nm)
c ASPR/A450
c DLSd UV−vise
Au5 1 10 510 1.26 4.4 ± 0.4 5
Au16 3.5 521 1.65 22.8 ± 2.1 16
Au32 2.5 525 N/A 32.1 ± 8.3 32
aAux:X = diameter of gold as determined by UV−vis spectroscopy. bNaBH4 used as reducing agent to obtain nanoparticles with diameter <10 nm.
cSPR, surface plasmon resonance. d± standard error from three measurements. eDetermined using the method of Haiss et al.35
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(>0.2 shift in Abs700; see the SI for cut-oﬀs and full data set).
To simplify, the results are represented as heat maps in Figure 3,
where green indicates a stable formulation and red unstable.
Clearly, 30 nm particles are unstable in LB when any amount
of PDMAEMA is included on their surface. Fifteen nm particles
will only tolerate a small amount of PDMAEMA at the longest
polymer chain length. In general, as particle size decreases the
stability increases; however, even going to 5 nm particles there
is not a combination of particle size and polymer length that is
stable at all PDMAEMA inclusions. The introduction of PHEA
increases stability, but for this study it was essential to be able
to screen the impact of PDMAEMA content across all com-
positions. This highlights the importance of considering the
stability of polymer−particle conjugates in complex media
instead of just assuming stability due to being stable in PBS
and suggests that other particle formations are probably less
stable but do not generate the strong signal outputs of AuNPs,
meaning it could go unnoticed.
With this information at hand, it was clear that smaller nano-
particles were essential to be able to obtain stable nanoparticles,
which were suitable for testing. To achieve this, a direct
reduction method employing polymers produced by the RAFT
process as capping groups was used as reported by Cameron
and coworkers40 to make ∼2 nm particles with the same
PDMAEMA combinations (Figure 4A). Only DP100 polymers
(PDMAEMA and PHEA) were used because the above
screening indicated that this would give us stable nanoparticles
across all compositions. Figure 4B shows a typical TEM image
(see SI for all particle TEMs) of the nanoparticles, conﬁrming
that they are ∼2 nm in diameter, in agreement with DLS (SI)
measurements showing that the particles are between 5 and
13 nm due to the hydrated polymer coating. Zeta potential of
these particles shows the particles are more positive with more
PDMAEMA incorporated as expected. Thermogravimetric
analysis (TGA, SI) revealed that these hybrid materials are
composed of 80% polymer:20% Au by mass. Full character-
ization of the library of particles made by this route is
summarized in Table 3. Because of the lack of SPR band in the
UV−vis spectra of these smaller particles, their increased
stability was instead probed by dynamic light scattering in both
water and in LB media (used for bacterial assays). In both cases
there was no aggregation over an 18 h period (SI).
This library of complex media-stable particles could then
be screened for antimicrobial activity against M. smegmatis
Figure 2. (A) Synthetic procedure for the production of antimicrobial nanoparticle library by a simple mix-and-match strategy. (B) DLS and
(C) UV−vis before (black) and after (red) functionalization of 32 nm particles with DP100 PHEA.
Figure 3. Heat maps showing stability of the 45 particle formulations
in (A) LB and (B) 7H9 supplemented with 0.2% glycerol and 0.05%
Tween 80, where red is unstable and green is stable.
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(a nonpathogenic model for M. tuberculosis) and E. coli
(a Gram-negative bacterial strain). The minimum inhibitory
concentration (MIC99) of the library was determined using a
resazurin cell viability assay. In brief, the particles were serially
diluted, bacterial cultures were added at 1 × 105 CFU·mL−1 and
grown over an appropriate time scale (16 h for E. coli and 24 h
for M. smegmatis), and resazurin (a blue, nonﬂuorescent, redox-
active dye) was added after this time period and left for 1 h for
E. coli and a further 24 h for M. smegmatis (standard method
due to its slower growth rate). The MIC99 was reported as the
lowest concentration at which resazurin was not reduced to
resoruﬁn (Figure 5 and Table 4).
As would be expected, as the cationic character of the
particles increased (increase in [PDMAEMA]), the MIC99
decreased (increase in antimicrobial activity) for both
M. smegmatis and E. coli. The antimicrobial activity is greater
for M. smegmatis over E. coli, which is the same trend as for the
polymers alone;33 however, the diﬀerence in response between
strains is signiﬁcantly less. Interestingly, this corresponded to an
eight-fold increase in activity (based on polymer concentration
determined by TGA) compared with the MIC99 of the polymer
alone for E. coli, whereas it is only a two-fold increase in activity
against M. smegmatis. This conﬁrms our hypothesis that the
mycobacteria interact with PDMAEMA by a unique mechanism
compared with Gram-negative bacteria.
These polymer−particle conjugates were further tested for
their antimicrobial activity against the two bacterial genera to
determine their minimum bactericidal concentration (MBC);
this assay determines if new compounds are bactericidal or
bacteriostatic. The minimum concentration to kill all of the
bacteria is reported in Figure 5 and Table 3. The MIC99 and
MBC correlate well for E. coli, as shown in Figure 5A, con-
ﬁrming that our method of presenting multiple copies of
polycations on the gold nanoparticle surface leads to a drastic
increase in bactericidal antimicrobial activity and oﬀers an easy
and practical route to enhancing activity. In contrast with the
above, the MIC99 values for M. smegmatis are considerably
lower than the MBCs with the MBC being up to eight times
the MIC99. This suggests that the particles are bactericidal
against E. coli but bacteriostatic against M. smegmatis, and hence
the same polymer functions against the diﬀerent genera by a
distinct mechanism. Such observations have broad implications
for the rational design of selective antimicrobials.
The core hypothesis of bactericidal activity by polycations
involves mechanisms that all lead to permeability or disruption
of the cell membrane.12 To probe this, LIVE/DEAD viability
Figure 4. (A) Synthetic scheme for direct particle formation. (B) Typical TEM of ∼2 nm particles formed by this method (100% PDMAEMA
particles) (rest in SI). (C) Histogram of particle sizes determined by image analysis in ImageJ by measurement of >100 particles.
Table 3. Summary of Particles Synthesized by the Direct Reduction Route
AuPDMAEMA% %PHEA100:%PDMAEMA100 size DLS (nm)
a size TEM (nm)b zeta potential (mV)c
Au0% 100:0 13.7 ± 1.4 1.7 ± 0.05 −3.4 ± 0.1
Au25% 75:25 13.6 ± 1.3 2.4 ± 0.09 11.8 ± 0.4
Au50% 50:50 8.1 ± 0.8 1.7 ± 0.06 15.7 ± 0.2
Au75% 25:75 6.5 ± 0.6 2.3 ± 0.06 19.2 ± 0.5
Au100% 0:100 5.3 ± 0.4 1.8 ± 0.04 23.2 ± 0.5
a± standard error from three measurements. b± standard error from at least 100 measurements. c± standard error from ﬁve measurements.
Biomacromolecules Article
DOI: 10.1021/acs.biomac.7b01561
Biomacromolecules 2018, 19, 256−264
261
assays were employed to probe the nature of the particle−
bacteria interaction and the ability of the particles to per-
meabilize the membranes. In this assay two dyes are used: a
green SYTO 9 membrane permeable nucleic acid stain that
indicates live cells and a red propidium iodide dye that is
only able to cross damaged membrane and indicates dead cells.
After incubation of the bacteria with particles below (0.5×) and
above (2×) their MIC99, they were visualized by ﬂuorescence
microscopy. Figure 6A shows that even at 2× MIC M. smegmatis
appear to have intact membranes, as judged by the green color of
the individual bacteria and absence of red. However, E. coli are
membrane-compromised even at 0.5× MIC (Figure 6B, red
coloration), which agrees with the concept that the particles are
acting with distinct modes of action against the two genera and
appear to perturb the membrane of the E. coli and are
bactericidal, whereas the particles inhibit the growth of
M. smegmatis but do not appear to kill the bacteria or cause
membrane damage. Growth inhibition but uncompromised
bacterial membranes of M. smegmatis were also observed in the
study by Feldheim et al.32 Fernandez-Trillo and coworkers
demonstrated that primary amine-terminated dendrimers
can induce clustering in Vibrio harveyi and that this process
resulted in growth inhibition at higher concentrations as well
as inducing membrane permeability,41 and they have shown
that cationic polymers can eﬀect quorum sensing in bacteria,
and such mechanisms cannot be ruled out here.23,42
The increase in valency from single polymer chains to
nanoparticles may also impact their unwanted interactions
with host cells, and hence the particles were tested for their
hemotoxicity against ovine red blood cells. It was determined
that they were not hemolytic with <5% hemolysis observed at
(6−200) × MIC99 of the particles (SI). For comparison,
Rotello et al.26 found their quarternized particles to be up to
25% hemolytic in their MIC range (4−128 nM). The particles
used here did, however, lead to some hemagglutination below
the MIC99 (data in the SI), which is not observed using the
polymers alone.33 This also correlated well with the study by
Feldheim et al.,32 which suggested that there were hemocom-
patibility issues associated with their mixed particles that
showed a similar mode of action against M. smegmatis, and the
nanoparticle surface needs ﬁne-tuning to resolve this.
■ CONCLUSIONS
We demonstrate the impact of the multivalent presentation of
cationic antimicrobial polymers at nanoparticle surfaces on
their antimicrobial activity against two diﬀerent genera of
bacteria and reveal distinct mechanisms of action that will
help guide future design. Using PDMAEMA as the cationic
polymer, a library (>50) nanoparticles ranging in diameter from
2 to 32 nm were synthesized, and the surface composition
varied by the addition of a noninteracting, noncharged second
polymer. It was found that only small (2 nm) particles lead to
stable dispersions: Large nanoparticles did display antimicrobial
activity, but the results were inconsistent and irreproducible
due to the lack of colloidal stability in complex media (despite
appearing stable in saline solutions alone). Against E. coli,
nanoparticle formulation of PDMAEMA leads to dramatic
increases in antimicrobial activity compared with the polymer
alone, which was found to be due to increased membrane
lysis and increases in both inhibitory and bactericidal activity.
Figure 5. Comparison of MIC99 and MBC for (A) E. coli and
(B) M. smegmatis. Values from three replicates, which each gave the
same value, and hence no variance is shown.
Table 4. Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations of Particles against E. coli and
M. smegmatis
E. coli M. smegmatis
particles
MIC99
(μg·mL−1 [Au])
MIC99
(μg·mL−1 [polymer])
MBC
(μg·mL−1 [Au])
MBC
(μg·mL−1 [polymer])
MIC99
(μg·mL−1 [Au])
MIC99
(μg·mL−1 [polymer])
MBC
(μg·mL−1 [Au])
MBC
(μg·mL−1 [polymer])
Au0% >1000 >4000 N/D
a N/Da >1000 >4000 N/Da N/Da
Au25% 62.5 250 125 500 31.25 125 250 1000
Au50% 31.3 125 31.3 125 15.6 62.5 250 1000
Au75% 15.6 62.5 15.6 62.5 7.8 31.3 250 1000
Au100% 7.8 31.3 7.8 31.25 3.9 15.6 125 500
PHEA >4000 N/D >4000 N/D
PDMAEMA 250 250 31.3 62.5
aNot determined due to no MIC99 in the concentration range tested.
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In stark contrast, against M. smegmatis (a surrogate for
M. tuberculosis) there was a less dramatic increase in activity
upon presenting polymers on the nanoparticle surface.
Mechanistic investigations showed that against E. coli, membrane
permeation and lysis was the primary mode of activity. Against
M. smegmatis, a bacteriostatic mode of action dominated, but
with no evidence of membrane lysis. These results are signiﬁcant,
as they show that there is not a universal strategy nor a “best
polymer” against all bacteria but that the structural compo-
sitions of the cell wall have a dramatic impact on antimicrobial
polymer function. These results will guide the development of
increasingly active and potential therapeutics as alternatives to
traditional small molecules and peptide-based antimicrobials.
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